Trial Profile

A Single-Centre, Double Blind, Randomized, Two-Way Cross-Over Study of Repeated Doses of AZD3480 and Single Dose of Warfarin to Evaluate the Pharmacokinetic Interaction of AZD3480 and Warfarin and the Effect of AZD3480 Pharmacodynamic in Healthy Male Subjects (Phase I)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Aug 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Apr 2009 Planned end date changed from 1 Jan 2009 to 1 May 2009 as reported by ClinicalTrials.gov
18 Apr 2009 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
12 Jan 2009 Status changed from recruiting to suspended due to the observation of a serious adverse event in another ispronicline trial according to ClinicalTrials.gov; the trial has been temporarily suspended during further evaluation.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com